683 ESTIMATING THE OVERALL SURVIVAL BENEFIT OF SIPULEUCEL-T IN THE IMPACT TRIAL ACCOUNTING FOR CROSSOVER TREATMENT IN CONTROL SUBJECTS WITH AUTOLOGOUS IMMUNOTHERAPY GENERATED FROM CYROPRESERVED CELLS

✍ Scribed by Gomella, Leonard; Nabhan, Chadi; DeVries, Todd; Whitmore, James; Frohlich, Mark; George, Daniel

• Book ID: 118485458
• Publisher: Lippincott Williams and Wilkins
• Year: 2012
• Tongue: English
• Weight: 59 KB
• Volume: 187
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2012.02.765